Michael-John Devlin
Impact in
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Ovarian cancer diagnosis and treatment 6
- Oncology 4
- PARP inhibition in cancer therapy 2
- Cancer Immunotherapy and Biomarkers 2
- Lung Cancer Research Studies 1
- Co-authors
- Martin Förster (1 shared paper)Kathleen N. Moore (1 shared paper)T.R. Jeffry Evans (2 shared papers)Jean‐Pierre Delord (1 shared paper)Valentina Boni (1 shared paper)José M. López-Picazo (1 shared paper)Tian Chen (1 shared paper)R. Wendel Naumann (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)International Journal of Gynecological Cancer (2 papers)Frontiers in Oncology (1 paper)Cancers (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United KingdomSwitzerlandUnited States
In The Last Decade
Michael-John Devlin
9 papers receiving 435 citations
Michael-John Devlin's Hit Papers
Peers
Comparison fields: 5 of 35
- Obstetrics and Gynecology 118
- Oncology 210
- Reproductive Medicine 49
- Immunology 100
- Otorhinolaryngology 19
Countries citing papers authored by Michael-John Devlin
This map shows the geographic impact of Michael-John Devlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael-John Devlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael-John Devlin more than expected).
Fields of papers citing papers by Michael-John Devlin
This network shows the impact of papers produced by Michael-John Devlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael-John Devlin. The network helps show where Michael-John Devlin may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael-John Devlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial Hit paper breakdown → | 2019 | 312 |
| 2 | 2018 | 88 | |
| 3 | 2022 | 23 | |
| 4 | 2025 | 10 | |
| 5 | 2022 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2018 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2017 | 1 | |
| 10 | 2023 | 0 | |
| 11 | 2018 | 0 |
About Michael-John Devlin
Michael-John Devlin is a scholar working on Reproductive Medicine, Oncology, Cancer Research, Obstetrics and Gynecology and Molecular Biology, having authored 11 papers that have together received 441 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (2 papers), PARP inhibition in cancer therapy (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Research Studies (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Obstetrics and Gynecology (118 citations), Oncology (210 citations), Reproductive Medicine (49 citations), Immunology (100 citations) and Otorhinolaryngology (19 citations). Michael-John Devlin has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Martin Förster, Kathleen N. Moore, T.R. Jeffry Evans, Jean‐Pierre Delord, Valentina Boni, José M. López-Picazo, Tian Chen, R. Wendel Naumann, Junchen Gu and Tim Meyer. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Gynecological Cancer, Frontiers in Oncology, Cancers and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.